• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿期后发作儿童的耐药性癫痫:临床特征与预测因素

Drug-resistant epilepsy in children post-neonatal seizures: Clinical profiles and predictors.

作者信息

Saenchai Warisara, Manopunya Satit, Kosarat Shanika, Khuwuthyakorn Varangthip, Tantiprabha Watcharee, Katanyuwong Kamornwan, Sanguansermsri Chinnuwat, Wiwattanadittakul Natrujee

机构信息

Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

出版信息

Brain Dev. 2025 Aug;47(4):104373. doi: 10.1016/j.braindev.2025.104373. Epub 2025 May 26.

DOI:10.1016/j.braindev.2025.104373
PMID:40424739
Abstract

OBJECTIVES

To investigate the clinical profile, etiologies, and outcomes of neonatal seizures and identify predictors of drug-resistant epilepsy (DRE) in children.

METHOD

A retrospective chart review was performed on neonates with seizures admitted to Chiang Mai University Hospital, Thailand, from January 2008 to December 2023. The diagnosis of neonatal seizures was based on clinical findings and/or electroencephalography. Severe impairment refers to limited mobility and minimal speech, while profound impairment indicates being bedridden. DRE is defined as the failure of two antiseizure medications to control seizures.

RESULTS

Among 218 patients (58.3 % male), the median seizure onset was 12 h (interquartile range [IQR]: 2.9-87 h). The leading etiology was perinatal asphyxia (58.7 %), followed by hemorrhage (7.8 %). The median follow-up was 27 months (IQR: 31.5 months). Epilepsy developed in 39 (27.3 %) patients, with 19 (48.7 %) meeting DRE criteria. Risk factors for epilepsy included marked abnormal neuroimaging, refractory neonatal seizures and severe to profound developmental impairment (P <0.05). In the multivariate model, profound developmental impairment (odds ratio [OR] = 2.89, p = 0.04, 95 % confidence interval [CI]: 1.79-24.19) and the development of epileptic spasms or multiple seizure types (OR = 114.80, p = 0.01, 95 % CI: 4.79-2746.07) were identified as an independent risk factor for DRE.

CONCLUSION

Perinatal asphyxia is the most common cause of neonatal seizures. One-third of neonates with seizures developed epilepsy, with half of them meeting the criteria for DRE. Neonates who develop epileptic spasms, exhibit multiple seizure types, or have profound developmental impairment are key DRE predictors.

摘要

目的

研究新生儿惊厥的临床特征、病因及预后,并确定儿童耐药性癫痫(DRE)的预测因素。

方法

对2008年1月至2023年12月在泰国清迈大学医院收治的惊厥新生儿进行回顾性病历审查。新生儿惊厥的诊断基于临床表现和/或脑电图。严重损伤是指活动受限和言语极少,而极重度损伤则指卧床不起。DRE定义为两种抗癫痫药物未能控制惊厥发作。

结果

在218例患者中(58.3%为男性),惊厥发作的中位时间为12小时(四分位间距[IQR]:2.9 - 87小时)。主要病因是围产期窒息(58.7%),其次是出血(7.8%)。中位随访时间为27个月(IQR:31.5个月)。39例(27.3%)患者发生癫痫,其中19例(48.7%)符合DRE标准。癫痫的危险因素包括明显异常的神经影像学检查、难治性新生儿惊厥以及重度至极重度发育障碍(P<0.05)。在多变量模型中,极重度发育障碍(比值比[OR]=2.89,p = 0.04,95%置信区间[CI]:1.79 - 24.19)以及癫痫痉挛或多种惊厥类型的出现(OR = 114.80,p = 0.01,95% CI:4.79 - 2746.07)被确定为DRE的独立危险因素。

结论

围产期窒息是新生儿惊厥最常见的原因。三分之一的惊厥新生儿发生癫痫,其中一半符合DRE标准。发生癫痫痉挛、表现出多种惊厥类型或有极重度发育障碍的新生儿是DRE的关键预测因素。

相似文献

1
Drug-resistant epilepsy in children post-neonatal seizures: Clinical profiles and predictors.新生儿期后发作儿童的耐药性癫痫:临床特征与预测因素
Brain Dev. 2025 Aug;47(4):104373. doi: 10.1016/j.braindev.2025.104373. Epub 2025 May 26.
2
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
3
Anti-seizure medications for neonates with seizures.抗癫痫药物治疗新生儿癫痫。
Cochrane Database Syst Rev. 2023 Oct 24;10(10):CD014967. doi: 10.1002/14651858.CD014967.pub2.
4
Idiopathic (Genetic) Generalized Epilepsy特发性(遗传性)全身性癫痫
5
Rufinamide add-on therapy for refractory epilepsy.鲁非酰胺辅助治疗难治性癫痫。
Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011772. doi: 10.1002/14651858.CD011772.pub2.
6
Real-world effectiveness and tolerability of cenobamate in drug-resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom.司替戊醇在耐药性癫痫中的真实世界有效性和耐受性:对德国、法国和英国早期准入项目(EAP)纳入患者的回顾性分析。
Epilepsia Open. 2025 Mar 22. doi: 10.1002/epi4.70021.
7
Brivaracetam add-on therapy for drug-resistant epilepsy.添加布瓦西坦治疗耐药性癫痫。
Cochrane Database Syst Rev. 2022 Mar 14;3(3):CD011501. doi: 10.1002/14651858.CD011501.pub3.
8
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.抗癫痫药物单药治疗癫痫:一项个体参与者数据的网络荟萃分析。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.
9
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001911. doi: 10.1002/14651858.CD001911.pub3.
10
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2015 Aug 14(8):CD001911. doi: 10.1002/14651858.CD001911.pub2.